Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 78920-10-2 | MDL No. : | MFCD11977490 |
Formula : | C7H10O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KQMCGGGTJKNIMC-UHFFFAOYSA-N |
M.W : | 142.15 | Pubchem ID : | 12864800 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.57 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 35.62 |
TPSA : | 46.53 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.77 cm/s |
Log Po/w (iLOGP) : | 1.53 |
Log Po/w (XLOGP3) : | 0.56 |
Log Po/w (WLOGP) : | 0.59 |
Log Po/w (MLOGP) : | 0.65 |
Log Po/w (SILICOS-IT) : | 0.97 |
Consensus Log Po/w : | 0.86 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.94 |
Solubility : | 16.2 mg/ml ; 0.114 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.11 |
Solubility : | 11.0 mg/ml ; 0.0777 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.73 |
Solubility : | 26.2 mg/ml ; 0.184 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96.3% | With morpholine In n-heptane at 40.1 - 41.7℃; for 18 h; Industrial scale | Example of industrial batch. All quantities of material were calculated with respect to the glyoxylic acid content of the 50percent w/w glyoxylic acid solution used. (0050) Heptane (1285kg, 1889L, 4.04vol) and morpholine (595L, 601.3kg, 6902mol, 1.09eq) were charged in the reactor. After addition of morpholine, the equipment was rinsed with heptanes (20L, 0.04vol). The solution was stirred at 22 - 23°C for 10min, before being cooled to 4.4°C. (0051) A 50percent aqueous solution of glyoxylic acid (935kg, 6318mol, 1.0eq) was slowly added while maintaining the temperature below 40°C. After addition of glyoxylic acid, the equipment was rinsed with heptanes (20L, 0.04vol). The medium was stirred for 2 hours at a temperature between 30.9 and 23.8°C. Valeraldehyde (706L, 576.8kg, 6697mol, 1.06eq) was then slowly added to the medium while maintaining the temperature below 40°C. (0052) After addition of valeraldehyde, the equipment was rinsed with heptanes (40L, 0.08vol). The reactor contents were heated between 40.1 and 41 .7°C for 18 hours 04 minutes. The medium was then cooled to 22.8°C and an aqueous solution of hydrochloric acid (1 168L, 1.73eq) was added while keeping the temperature between 23.5 and 25.0°C; the medium was stirred for 4 hours. (0053) The medium was allowed to separate and the organic phase was removed. The aqueous phase was washed with heptanes (3x943L, 3x2vol). Diisopropyl ether (1322kg, 1888L, 4.04vol) was added to the aqueous phase followed by solid sodium carbonate (199kg) until a pH value of 0.4 was reached. The medium was allowed to separate and the organic phase was removed. Compound (II) was extracted from the aqueous phase with diisopropyl ether (2x530kg, 2x756L, 2x1 .6vol). The combined organic phases were washed with a 20percent w/w aqueous solution of sodium chloride (944.2kg, 1.6vol). The organic layer was then dried by azeotropic distillation under vacuum at a jacket temperature of maximum 40°C and filtered. The solution was finally concentrated under vacuum below 40°C and a polish filtration through a 10μηι cartridge filter was performed. The total mass of solution (934.9kg) was corrected for the water content (3.7percent) and the DIPE content (3.8percent) to give 864.8kg of compound (II) (6084mol, 96.3percent yield). |
92.5% | at 10 - 45℃; for 7 h; Large scale | 50percent aqueous glyoxylic acid (6kg, 41.1mol) was added to a 50L autoclave, n-heptane (10L), water (3L), cooled to below 10 , it quickly added film (3.57kg, 41.1mol), warmed to 25 , the reaction for 2h, n-valeraldehyde (3.53kg, 41.1mol), completion of the addition was warmed to 45 , reaction 5h, cooled to below 10 , rapid concentrated hydrochloric acid (5L), the reaction 3h, liquid separation, washed with 30percent aqueous sodium bicarbonate n-heptane phase is separated off, and washing with n-heptane phase (3L × 3), the aqueous phase was extracted with diisopropyl ether (6L × 3) with, respectively, diisopropyl ether phase concentration (3L × 2), saturated brine (3L × 1), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to 45 with isopropyl ether, to give a dark yellow product was 5.387kg, HPLC: 98percent pure, a yield of 92.5percent |
55% | With piperidine hydrochloride In 1,4-dioxane; water for 18 h; Inert atmosphere; Reflux | Glyoxilic acid monohydrate (4.55 g, 49.42 mmol) and piperidine hydrochloride (6.30 g, 51.80 mmol) were added to a solution of pentanal (5 mL, 47.02 mmol) in 7:1 dioxane:water (25 mL) under nitrogen. The mixture was heated at reflux for 18 h and, after cooling to room temperature, diluted with 2 M HCl (100 mL) and extracted with diisopropyl ether (3 × 30 mL). The first extract was discharged, while the other two were combined and extracted with 2 M HCl (3 × 30 mL). These three acidic extracts were combined with the reaction mixture, which had been previously diluted with 2 M HCl, and washed with diisopropyl ether, and the whole aqueous layer was extracted with DCM (3 × 80 mL). The DCM extracts were concentrated to give 4a (3.68 g, 55percent) as an oil. 1H NMR (300 MHz, CDCl3) δ 6.00 (s, 1H), 5.84 (t, J = 1.8 Hz, 1H), 4.65 (bs, 1H, exchange with D2O), 2.25–2.52 (m, 2H), 1.52–1.77 (m, 2H), 1.00 (t, J = 7.6 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 172.3, 170.3, 117.2, 99.4, 29.6, 19.9, 13.7. Anal. calcd. for C7H10O3: C, 59.14; H, 7.09. Found: C, 58.98; H, 7.13. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90.8% | Stage #1: With morpholine In n-heptane; water at 20℃; for 1 h; Stage #2: at 43℃; for 20 h; Stage #3: With hydrogenchloride In n-heptane; water at 20℃; for 2 h; |
Heptane (394 ml) and morpholine (127.5 ml) are introduced in a reactor. The mixture is cooled to 0°C and glyoxylic acid (195 g, 150 ml, 50Wpercent in water) is added. The mixture is heated at 20°C during 1 hour, and then valeraldehyde (148.8 ml) is added. The reaction mixture is heated at 43°C during 20 hours. After cooling down to 20°C, a 37 percent aqueous solution OF HCL (196.9 ml) is slowly added to the mixture, which is then stirred during 2 hours. After removal of the heptane phase, the aqueous phase is washed three times with heptane. Diisopropyl ether is added to the aqueous phase. The organic phase is removed, and the aqueous phase further extracted with diisopropyl ether (2x). The diisopropyl ether phases are combined, washed with brine and then dried by azeotropic distillation. After filtration and evaporation of the solvent, 170g of 5- HYDROXY-4-N-PROPYL-FURAN-2-ONE are obtained as a brown oil. Yield: 90.8 percent |
[ 1143-70-0 ]
3,8-Dihydroxy-6H-benzo[c]chromen-6-one
Similarity: 0.55
[ 6950-82-9 ]
2-(7-Hydroxy-2-oxo-2H-chromen-4-yl)acetic acid
Similarity: 0.54
[ 107859-98-3 ]
Ethyl 3-(4-(hydroxymethyl)phenyl)propanoate
Similarity: 0.53
[ 69716-04-7 ]
2-(6-Hydroxybenzofuran-3-yl)acetic acid
Similarity: 0.53
[ 86971-83-7 ]
Methyl 3,4-Dihydro-2H-pyran-5-carboxylate
Similarity: 0.65
[ 15963-40-3 ]
Methyl 3-methylenecyclobutanecarboxylate
Similarity: 0.62
[ 145576-28-9 ]
Ethyl 4-methylenecyclohexanecarboxylate
Similarity: 0.60
[ 36878-91-8 ]
Ethyl 3-(furan-3-yl)-3-oxopropanoate
Similarity: 0.55
[ 35351-35-0 ]
Methyl 5-methylfuran-3-carboxylate
Similarity: 0.52